Alternatively, it may simply not be possible to mimic all aspects of the neuropathology of AD in mice because specific metabolisms present only in humans are required [such as differences in microglia between humans and mice (Galatro et al., 2017) or in the sequence of the tau protein (Hernández et al., 2020)]. The gene discussed is MAPT; the disease is Alzheimer disease.